Current News
Secukinumab and TNF-α inhibitors' effect on the humoral response to BNT162b2 mRNA vaccine in spondyloarthritis patients compared to immunocompetent controls
Secukinumab and TNF-α inhibitors' effect on the humoral response to BNT162b2 mRNA vaccine in spondyloarthritis patients compared to immunocompetent controls 2023-11-01 04:00:00
